Axitinib induces senescence-associated cell death and necrosis in glioma cell lines: The proteasome inhibitor, bortezomib, potentiates axitinib-induced cytotoxicity in a p21(Waf/Cip1) dependent manner Figure S1 : Axitinib effects on glioma cell lines. A. U87, T98 and U251 cell lines were cultured up to 72 h with different doses of axitinib. Cell viability was determined by MTT assay. Data shown are expressed as mean ± SD of three separate experiments; *p<0.01 vs untreated cells. B. Representative cell cycle distribution in glioma cells treated with axitinib (5 μM for U87 and T98, 15 μM for U251) for up to 72 h. C. Cells were treated with axitinib for 72 h and then stained with NAO, used to evaluate total mitochondrial mass. NAO staining was quantified using flow cytometry and is displayed as a histogram. Data are expressed as percentage of NAO positive cells with respect to untreated cells. D. U87 and T98 cells were treated as above described and then Annexin V staining was analyzed by flow cytometry. Histograms are representative of one of three separate experiments. E. Representative immunoblot of caspase-3 in glioma cells treated as above described. GAPDH was used as loading control. 
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